Y-Intercept (HK)’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,077
Closed -$205K 1841
2023
Q4
$205K Sell
1,077
-7,458
-87% -$1.41M 0.02% 996
2023
Q3
$1.7M Buy
8,535
+3,985
+88% +$942K 0.17% 178
2023
Q2
$1.3M Buy
+4,550
New +$1.26M 0.14% 206
2023
Q1
Sell
-4,382
Closed -$901K 1633
2022
Q4
$901K Buy
+4,382
New +$1.11M 0.13% 226
2022
Q1
Sell
-1,871
Closed -$334K 1007
2021
Q4
$334K Buy
1,871
+462
+33% +$91.1K 0.08% 367
2021
Q3
$290K Buy
+1,409
New +$277K 0.05% 473

Other funds holding SWAV

Y-Intercept (HK)'s SWAV Position: Q1 2024 in Review

Y-Intercept (HK) sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,077 shares — an estimated $205K sold.

Y-Intercept (HK) first reported a position in SWAV in Q3 2021 and held it in 6 quarters. The position peaked at $1.7M in Q3 2023. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • Y-Intercept (HK) reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 1,077 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $205K.
  • Y-Intercept (HK) first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Y-Intercept (HK)'s Shockwave Medical, Inc. Common Stock position peaked at $1.7M in Q3 2023.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Y-Intercept (HK)'s 13F filing for Q1 2024, filed 10 May 2024.